Biography

Neil Desai is the Founder, CEO, and Chairman of Aanastra, Inc., and cofounder of Divincell SAS, two companies at the forefront of developing peptide-based RNA therapeutic drug delivery for cancer and genetic diseases. He also founded Aadi Bioscience, where he served as CEO and now acts as Executive Chairman. Under his leadership, Aadi went public in August 2021.

Neil is the inventor of nab technology and led the teams that developed and secured approval for nab-sirolimus (FYARRO) and nab-paclitaxel (ABRAXANE). He was previously Senior VP of Global R&D at Abraxis Bioscience and later VP of Strategic Platforms at Celgene.